LLY
ELI LILLY AND COMPANYNYSEResearch view
Healthcare · Pharmaceutical Preparations · Mega-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$1,071B
Enterprise Value$1,106B
Income$20.6B
Sales$65.2B
Book/sh$28.19
Cash/sh$7.72
Dividend TTM$6.23
Payout26%
Employees—
IPO—
Quick Ratio1.19
Current Ratio1.58
Debt/Eq1.60
EPS (ttm)$22.95
EPS this Y96.0%
EPS past 3/5Y49.3%
Sales past 3/5Y31.7%
EPS Y/Y TTM96.0%
Sales Y/Y TTM44.7%
Shs Outstand941.36M
ROA18.4%
ROE77.8%
ROIC—
Gross Margin—
Oper. Margin—
Profit Margin31.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$28.3B
2021
$28.5B
2022
$34.1B
2023
$45.0B
2024
$65.2B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $5.6B | $6.2B | $5.2B | $10.6B | $20.6B |
| Diluted EPS | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |
| Operating Cash Flow | $7.4B | $7.6B | $4.2B | $8.8B | $16.8B |
| Free Cash Flow | — | — | — | — | — |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $LLY0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Pharmaceutical Preparations
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.